Ultrasound-guided Radiofrequency Ablation of Malignant Hepatic Tumors

陈敏华,刘吉斌,严昆,武金玉,霍苓,杨仁杰,张晓鹏,黄信孚

DOI: https://doi.org/10.3760/j.issn:1004-4477.2001.07.006

2001-01-01

Abstract:Objective To evaluate the efficacy of ultrasound guided radiofrequency ablation (RFA) in primary and secondary hepatic cancers.Methods Ninety two patients with 132 tumors were treated with RFA from December 1999 to January 2001. Of these, 55 cases were primary liver cancer and 37 cases were hepatic metastases. The median of lesion size was 3.2 cm ( 1.5 ～ 8.0 cm). Three patients were treated intraoperatively and the others were treated percutaneously in clinic. All patients were followed up using contrast enhanced CT postoperatively.Results One hundred and twenty lesions were completely ablated according to contrast enhanced CT. Thus, the total response was 90.9 %(120/132). Among these patients, 21 cases ( 22.8 %) were treated with RFA 2～4 times. In 3 months after RFA, most lesions were demonstrated a progressive decrease in size. The massive bleeding of an enormous liver cancer with spontaneous rupture was stopped successfully by RFA during emergent operation.Of patients followed up for 3～16 months,89 were alive, 3 died due to other causes.The significant treatment related complications occurred in 3 of the 92 patients ( 3.2 %), including one hemorrhage stopped by RFA, one liver incompetence and one temporary dilatation of hepatic duct. Conclusions Ultrasound guided RFA seems to be an effective minimally invasive treatment technique for patients with malignant hepatic tumor. It's also very important to perform RFA in a proper technique and select indications for treatment. RFA seems to be an option to treat hemorrhage of patients with ruptured hepatic tumors.